Liberty Expedia Holdings (LEXEB:NAS) and Ophthotech (OPHT:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEB Liberty Expedia Holdings Inc 47.898300 57276969 None 1.0904 55.75 -28.30
LEXEA Liberty Expedia Holdings Inc 46.350000 57276969 None 1.0552 55.75 -28.30
SOHU Sohu.com Ltd 21.590000 38916788 None 1.2647 29.71 23.98
PDLI PDL BioPharma Inc 2.340000 145400381 3.6029 0.4774 2.72 1.89
NLNK NewLink Genetics Corp 2.890000 37214286 None 0.8608 3.68 3.68
SCPH scPharmaceuticals Inc 5.290000 18569289 None 1.1088 5.43 4.91
OPHT Ophthotech Corp 2.380000 36198436 0.5587 4.9146 4.03 5.82
AQXP Aquinox Pharmaceuticals Inc 3.180000 23537368 None 0.8254 4.21 4.21
VSAR Versartis Inc 1.800000 36240673 None 0.9463 1.87 1.67
VBLT Vascular Biogenics Ltd 1.600000 35855461 None 0.9395 1.63 1.03
APWC Asia Pacific Wire & Cable Corp Ltd 2.683800 13819669 9.2545 0.2344 3.91 1.37
GIGM GigaMedia Ltd 3.010000 11052235 32.0000 0.5587 5.50 5.77
ASNS Arsanis Inc 1.890000 14315410 None 0.7165 3.49 2.71
VXRT Vaxart Inc 3.160000 7141189 None 1.0095 3.35 2.72
GEMP Gemphire Therapeutics Inc 1.440000 14265411 None 1.3651 1.97 1.25
PTX Pernix Therapeutics Holdings Inc 1.350000 13920264 None None 1.43 -18.77
CYCC Cyclacel Pharmaceuticals Inc 1.550000 11997447 None 0.9985 1.65 0.96
NVIV InVivo Therapeutics Holdings Corp 1.960000 7763420 None 1.8562 2.88 2.83
ABAC Renmin Tianli Group Inc 1.900000 7983745 23.7500 0.1702 7.87 7.61
ACHV Achieve Life Sciences Inc 3.050000 4551005 0.0205 0.8442 3.36 0.92
DCIX Diana Containerships Inc 1.350000 9958935 None 0.1395 2.35 -0.57
ATOS Atossa Genetics Inc 2.170000 5069559 0.0710 0.8109 3.01 1.55
RTTR Ritter Pharmaceuticals Inc 1.930000 5534639 None 1.0007 2.94 None
KBSF KBS Fashion Group Ltd 3.905000 2206741 None 0.1196 10.93 10.21
AYTU Aytu BioScience Inc 4.410000 1794153 None 0.6206 6.69 4.82

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

LEXEB:NAS Liberty Expedia Holdings

http://www.libertyexpedia.com
Liberty Expedia Holdings has 23101 employees and is headquartered in United States.
Liberty Expedia Holdings Inc is an online travel company. It operates a strong brand portfolio with global reach, targeting a broad range of travelers, travel suppliers, and advertisers.

OPHT:NAS Ophthotech

http://www.ophthotechinc.com
Ophthotech has 41 employees and is headquartered in United States.
Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate is called as Fovista.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.